WO2008133198A1 - 神経突起形成促進剤 - Google Patents
神経突起形成促進剤 Download PDFInfo
- Publication number
- WO2008133198A1 WO2008133198A1 PCT/JP2008/057583 JP2008057583W WO2008133198A1 WO 2008133198 A1 WO2008133198 A1 WO 2008133198A1 JP 2008057583 W JP2008057583 W JP 2008057583W WO 2008133198 A1 WO2008133198 A1 WO 2008133198A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- promoter
- neurite
- formation
- corneal
- formation promoter
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008800212987A CN101687795B (zh) | 2007-04-20 | 2008-04-18 | 轴突形成促进剂 |
US12/596,581 US8637544B2 (en) | 2007-04-20 | 2008-04-18 | Neurite formation promoter |
EP08740638.5A EP2157082B1 (en) | 2007-04-20 | 2008-04-18 | Neurite formation promoter |
BRPI0810093-4A2A BRPI0810093A2 (pt) | 2007-04-20 | 2008-04-18 | Promotor de formação de nevrite |
KR1020097024102A KR101486605B1 (ko) | 2007-04-20 | 2008-04-18 | 신경돌기 형성 촉진제 |
CA2684561A CA2684561C (en) | 2007-04-20 | 2008-04-18 | Neurite formation promoter |
JP2009511854A JP5179477B2 (ja) | 2007-04-20 | 2008-04-18 | 神経突起形成促進剤 |
ES08740638.5T ES2577539T3 (es) | 2007-04-20 | 2008-04-18 | Promotor de la formación de neuritas |
MX2009011250A MX2009011250A (es) | 2007-04-20 | 2008-04-18 | Promotor de la formacion de neuritas. |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007-112248 | 2007-04-20 | ||
JP2007112248 | 2007-04-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2008133198A1 true WO2008133198A1 (ja) | 2008-11-06 |
Family
ID=39925652
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2008/057583 WO2008133198A1 (ja) | 2007-04-20 | 2008-04-18 | 神経突起形成促進剤 |
Country Status (11)
Country | Link |
---|---|
US (1) | US8637544B2 (ja) |
EP (1) | EP2157082B1 (ja) |
JP (1) | JP5179477B2 (ja) |
KR (1) | KR101486605B1 (ja) |
CN (2) | CN103251592B (ja) |
BR (1) | BRPI0810093A2 (ja) |
CA (1) | CA2684561C (ja) |
ES (1) | ES2577539T3 (ja) |
MX (1) | MX2009011250A (ja) |
RU (1) | RU2442582C2 (ja) |
WO (1) | WO2008133198A1 (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10435444B2 (en) | 2015-04-17 | 2019-10-08 | The University Of Tokyo | Agent for prevention or treatement of corneal disorders |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000042011A1 (en) | 1999-01-14 | 2000-07-20 | Fujisawa Pharmaceutical Co., Ltd. | Amide compounds |
WO2000072834A2 (en) | 1999-05-28 | 2000-12-07 | Fujisawa Pharmaceutical Co., Ltd. | Agent for expression of long-term potentiation of synaptic transmission comprising compound having brain somatostatin activation property |
WO2003084542A1 (fr) | 2002-04-10 | 2003-10-16 | Fujisawa Pharmaceutical Co., Ltd. | Accelerateur de production d'un facteur neurotrophique |
WO2004039403A1 (ja) | 2002-10-31 | 2004-05-13 | Senju Pharmaceutical Co., Ltd. | 角膜障害治療剤 |
JP2007112248A (ja) | 2005-10-19 | 2007-05-10 | Nissan Motor Co Ltd | 駆動系の制振制御装置 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITRM20010755A1 (it) * | 2001-12-20 | 2003-06-20 | Simonelli Giuseppe | Uso del chinone q10 per il trattamento delle malattie oculari. |
CN100413538C (zh) * | 2002-10-31 | 2008-08-27 | 千寿制药株式会社 | 角膜疾病治疗剂 |
EP1991212A1 (en) | 2006-03-08 | 2008-11-19 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
-
2008
- 2008-04-18 KR KR1020097024102A patent/KR101486605B1/ko active IP Right Grant
- 2008-04-18 EP EP08740638.5A patent/EP2157082B1/en active Active
- 2008-04-18 ES ES08740638.5T patent/ES2577539T3/es active Active
- 2008-04-18 US US12/596,581 patent/US8637544B2/en active Active
- 2008-04-18 WO PCT/JP2008/057583 patent/WO2008133198A1/ja active Application Filing
- 2008-04-18 CN CN201310119415.6A patent/CN103251592B/zh active Active
- 2008-04-18 MX MX2009011250A patent/MX2009011250A/es active IP Right Grant
- 2008-04-18 CA CA2684561A patent/CA2684561C/en active Active
- 2008-04-18 RU RU2009142843/15A patent/RU2442582C2/ru active
- 2008-04-18 BR BRPI0810093-4A2A patent/BRPI0810093A2/pt not_active Application Discontinuation
- 2008-04-18 JP JP2009511854A patent/JP5179477B2/ja active Active
- 2008-04-18 CN CN2008800212987A patent/CN101687795B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000042011A1 (en) | 1999-01-14 | 2000-07-20 | Fujisawa Pharmaceutical Co., Ltd. | Amide compounds |
WO2000072834A2 (en) | 1999-05-28 | 2000-12-07 | Fujisawa Pharmaceutical Co., Ltd. | Agent for expression of long-term potentiation of synaptic transmission comprising compound having brain somatostatin activation property |
WO2003084542A1 (fr) | 2002-04-10 | 2003-10-16 | Fujisawa Pharmaceutical Co., Ltd. | Accelerateur de production d'un facteur neurotrophique |
WO2004039403A1 (ja) | 2002-10-31 | 2004-05-13 | Senju Pharmaceutical Co., Ltd. | 角膜障害治療剤 |
JP2007112248A (ja) | 2005-10-19 | 2007-05-10 | Nissan Motor Co Ltd | 駆動系の制振制御装置 |
Non-Patent Citations (15)
Title |
---|
ANG ET AL., CURR OPIN OPHTHALMOL., vol. 12, 2001, pages 318 |
ANG, R. T. ET AL., CURRENT OPINION IN OPHTHALMOLOGY, vol. 12, 2001, pages 318 - 322 |
ARBELAEZ MC. ET AL., J. REFRACT SURG., vol. 18, no. 3, May 2002 (2002-05-01), pages 357 - 60 |
BRAGHEETH M.A. ET AL.: "Corneal sensation after myopic and hyperopic LASIK: clinical and confocal microscopic study", BR J OPHTHALMOL, vol. 89, no. 5, May 2005 (2005-05-01), pages 580 - 585, XP008121801 * |
CLAO J., vol. 26, 2000, pages 159 |
FUJISHIMA ET AL., CORNEA, vol. 15, 1996, pages 368 |
KWAN Y. CHAN; RICHARD H. HASCHKE., EXP. EYE RES., vol. 41, 1985, pages 687 - 699 |
OTORI Y; WEI JY; BARNSTABLE CJ., INVEST. OPHTHALMOL VIS SCI, vol. 39, 1998, pages 972 - 981 |
See also references of EP2157082A4 * |
SOLOMON, R. ET AL., THE OCULAR SURFACE, vol. 2, 2004, pages 34 - 42 |
TOKITA, K. ET AL., EUROPEAN JOURNAL OF PHARMACOLOGY, vol. 527, 2005, pages LLL-120 |
TUULI, U. L. ET AL., EXPERIMENTAL EYE RESEARCH, vol. 66, 1998, pages 755 - 763 |
TUULI, U. L. ET AL., INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, vol. 41, 2000, pages 393 - 397 |
XU ET AL., CORNEA, vol. 15, 1996, pages 235 |
XU, K.-T. ET AL., CORNEA, vol. 15, 1996, pages 235 - 239 |
Also Published As
Publication number | Publication date |
---|---|
ES2577539T3 (es) | 2016-07-15 |
KR101486605B1 (ko) | 2015-01-26 |
CN101687795A (zh) | 2010-03-31 |
JPWO2008133198A1 (ja) | 2010-07-22 |
RU2009142843A (ru) | 2011-05-27 |
EP2157082B1 (en) | 2016-06-08 |
CN103251592A (zh) | 2013-08-21 |
CN103251592B (zh) | 2015-07-29 |
CA2684561A1 (en) | 2008-11-06 |
RU2442582C2 (ru) | 2012-02-20 |
MX2009011250A (es) | 2009-11-05 |
US20100144792A1 (en) | 2010-06-10 |
JP5179477B2 (ja) | 2013-04-10 |
EP2157082A1 (en) | 2010-02-24 |
EP2157082A4 (en) | 2011-03-30 |
KR20090130142A (ko) | 2009-12-17 |
BRPI0810093A2 (pt) | 2014-10-21 |
CA2684561C (en) | 2015-06-30 |
CN101687795B (zh) | 2013-05-08 |
US8637544B2 (en) | 2014-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2009134371A3 (en) | Composite lacrimal insert and related methods | |
WO2008029276A3 (en) | Compositions and methods for the treatment of ophthalmic disease | |
WO2006071548A3 (en) | Aminopyrazine analogs for treating glaucoma and other rho kinase-mediated diseases | |
WO2009105690A3 (en) | Devices and methods for delivering polynucleotides into retinal cells of the macula and fovea | |
TW200833341A (en) | 6-aminoimidazo[1,2-b]pyridazine analogs as rho kinase inhibitors for the treatment of rho kinase-mediated diseases and conditions | |
WO2006091522A3 (en) | Methods for modulating macrophage proliferation in ocular disease using polyamine analogs | |
MX2010002617A (es) | Implantes lagrimales y metodos relacionados. | |
WO2006105403A3 (en) | Treatment of eye disorders with sirtuin modulators | |
WO2018033792A3 (en) | Ophthalmic pharmaceutical compositions and uses relating thereto | |
WO2011014587A3 (en) | Ophthalmic pharmaceutical compositions of dp2 receptor antagonists | |
TW200744574A (en) | Use of L-carnitine or of alkanoyl L-carnitines for the preparation of a physiological supplement of medicament for ophthalmic use in the form of eye-drops | |
WO2006017188A3 (en) | Memantine as adjunctive treatment to atypical antipsychotics in schizophrenia patients | |
WO2009024677A3 (fr) | Utilisation d ' acide hyaluronique pour la preparation de compositions destinees a l' amelioration de la fonction de protection de la peau, de l' oeil et des muqueuses | |
WO2008140052A1 (ja) | ロピニロール又はその塩を有効成分として含有する後眼部疾患の予防又は治療剤 | |
WO2007117971A3 (en) | Ocular allergy treatments | |
WO2015023884A3 (en) | Timed release of substances to treat ocular disorders | |
WO2011076368A3 (en) | Topical ophthalmic peptide formulation | |
WO2008063639A3 (en) | Compositions and methods for preserving cells of the eye | |
CL2007003836A1 (es) | Uso de compuestos derivados de isosorbide en la prevencion y/o tratamiento de enfermedades oftalmologicas mediadas por hipertension ocular, tales como glaucoma. | |
DE502005008759D1 (de) | In vitro aus knochenmarkstammzellen differenzierteerwendung | |
NZ602479A (en) | Pharmaceutical composition for the treatment of dry eye and/or corneal and conjunctival lesion | |
RU2017118405A (ru) | Новое лечение роговицы с применением ламинина | |
WO2007039123A3 (en) | Combination therapy comprising an nk-3 antagonist and an antipsychotic agent | |
WO2011137344A3 (en) | Anti-s1p antibody treatment of patients with ocular disease | |
WO2013184650A3 (en) | Treatment of ocular inflammatory diseases using laquinimod |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200880021298.7 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08740638 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2009511854 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2684561 Country of ref document: CA Ref document number: MX/A/2009/011250 Country of ref document: MX |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008740638 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 20097024102 Country of ref document: KR Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009142843 Country of ref document: RU Ref document number: 6842/CHENP/2009 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12596581 Country of ref document: US |
|
ENP | Entry into the national phase |
Ref document number: PI0810093 Country of ref document: BR Kind code of ref document: A2 Effective date: 20091020 |